{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:05:33Z","timestamp":1779242733522,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04272-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:24:13Z","timestamp":1775809453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-positive anti-aminoacyl-tRNA synthetase and anti-melanoma differentiation-associated gene 5 antibody-related rapidly progressive interstitial lung disease in a patient with severe coronavirus disease 2019 complicated by probable pulmonary aspergillosis and pneumothorax: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Kazuki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Koshimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"4272_CR1","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.chest.2023.01.031","volume":"163","author":"RW Hallowell","year":"2023","unstructured":"Hallowell RW, Danoff SK. Diagnosis and management of myositis-associated lung disease. Chest. 2023;163:1476\u201391.","journal-title":"Chest"},{"key":"4272_CR2","doi-asserted-by":"publisher","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE. 2013;8:e60442.","journal-title":"PLoS ONE"},{"key":"4272_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrrheum.2016.120","volume":"12","author":"T Gono","year":"2016","unstructured":"Gono T, Kuwana M. Inflammatory myopathies: choosing the right biomarkers to predict ILD in myositis. Nat Rev Rheumatol. 2016;12:504\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"4272_CR4","doi-asserted-by":"publisher","first-page":"987841","DOI":"10.3389\/fimmu.2022.987841","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, et al. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody dual-positive dermatomyositis patients. Front Immunol. 2022;13:987841.","journal-title":"Front Immunol"},{"key":"4272_CR5","unstructured":"Japanese Association for Infectious Diseases, Society JR, Japanese Society of Intensive Care Medicine, Japanese Association for Acute Medicine., Japanese Society of Chemotherapy. Guidance for the treatment of COVID-19 by five academic societies in Japan, version 1. 2025. https:\/\/www.kansensho.or.jp\/uploads\/files\/topics\/2019ncov\/covid_251017.pdf. Accessed 11 Feb 2026."},{"key":"4272_CR6","doi-asserted-by":"publisher","first-page":"102666","DOI":"10.1016\/j.autrev.2020.102666","volume":"19","author":"E De Lorenzis","year":"2020","unstructured":"De Lorenzis E, Natalello G, Gigante L, Verardi L, Bosello SL, Gremese E. What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Autoimmun Rev. 2020;19:102666.","journal-title":"Autoimmun Rev"},{"key":"4272_CR7","doi-asserted-by":"publisher","first-page":"2001618","DOI":"10.1183\/13993003.01618-2020","volume":"56","author":"M Giannini","year":"2020","unstructured":"Giannini M, Ohara M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J. 2020;56:2001618.","journal-title":"Eur Respir J"},{"key":"4272_CR8","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149\u201362.","journal-title":"Lancet Infect Dis"},{"key":"4272_CR9","first-page":"3","volume":"1","author":"T Naniwa","year":"2017","unstructured":"Naniwa T, Tamechika S, Okazaki Y, Maeda S, Kuwana M. Coexistence of anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-transfer RNA synthetase antibodies in a patient with dermatomyositis and rapidly progressive and relapsing interstitial lung disease. Med Rheumatol Case Rep. 2017;1:3\u20138.","journal-title":"Med Rheumatol Case Rep"},{"key":"4272_CR10","doi-asserted-by":"publisher","first-page":"rky022","DOI":"10.1093\/rap\/rky022","volume":"2","author":"Y Takeuchi","year":"2018","unstructured":"Takeuchi Y, Hashimoto M, Nakashima R, Tanaka M, Kuramoto N, Murakami K, et al. Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report. Rheumatol Adv Pract. 2018;2:rky022.","journal-title":"Rheumatol Adv Pract"},{"key":"4272_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12890-020-01256-x","volume":"20","author":"ZY Li","year":"2020","unstructured":"Li ZY, Gill E, Mo F, Reyes C. Double anti-PL-7 and anti-MDA-5 positive amyopathic dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient. BMC Pulm Med. 2020;20:220.","journal-title":"BMC Pulm Med"},{"key":"4272_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2169\/internalmedicine.8579-21","volume":"61","author":"S Hama","year":"2022","unstructured":"Hama S, Higashitani-Konishi M, Akiyama M, Shimada T, Takei H, Izumi K, et al. Dermatomyositis which was double positive for anti-MDA5 and anti-ARS antibodies that was successfully treated by intensive immunosuppressive therapy. Intern Med. 2022;61:1085\u201391.","journal-title":"Intern Med"},{"key":"4272_CR13","first-page":"101606","volume":"36","author":"T Hiramatsu","year":"2022","unstructured":"Hiramatsu T, Murano M, Nakai S, Murakami Y, Nishimoto K, Matsushima S, et al. Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies. Respir Med Case Rep. 2022;36:101606.","journal-title":"Respir Med Case Rep"},{"key":"4272_CR14","doi-asserted-by":"publisher","first-page":"e6840","DOI":"10.1002\/ccr3.6840","volume":"11","author":"H Fu","year":"2023","unstructured":"Fu H, Sun S, Zhang H, Chi S, Ma W, Yang G, et al. Coexistence of anti-MDA5 and anti-PL-7 in a patient with dermatomyositis: a case report. Clin Case Rep. 2023;11:e6840.","journal-title":"Clin Case Rep"},{"key":"4272_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1684\/ejd.2024.4742","volume":"34","author":"S Matsumoto","year":"2024","unstructured":"Matsumoto S, Hamaguchi Y, Kitano T, Takehara K, Oishi K, Maeda S, et al. A case of dermatomyositis with positivity to both anti-MDA5 and anti-ARS antibodies. Eur J Dermatol. 2024;34:444\u20136.","journal-title":"Eur J Dermatol"},{"key":"4272_CR16","first-page":"148","volume":"13","author":"M Fujiwara","year":"2024","unstructured":"Fujiwara M, Watanabe H, Goda M, Fujiwara K, Ota K, Shibayama T. A case of dermatomyositis double positive for anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-tRNA synthetase antibodies with treatment-resistant myositis. Ann Jpn Respir Soc. 2024;13:148\u201354.","journal-title":"Ann Jpn Respir Soc"},{"key":"4272_CR17","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M, et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology (Oxford). 2018;57:1212\u201321.","journal-title":"Rheumatology (Oxford)"},{"key":"4272_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2012;51:1563\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"4272_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3899\/jrheum.180825","volume":"46","author":"T Fujisawa","year":"2019","unstructured":"Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, et al. Clinical significance of serum chitotriosidase level in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease. J Rheumatol. 2019;46:935\u201342.","journal-title":"J Rheumatol"},{"key":"4272_CR20","doi-asserted-by":"publisher","first-page":"1565803","DOI":"10.3389\/fimmu.2025.1565803","volume":"16","author":"S Lattarulo","year":"2025","unstructured":"Lattarulo S, Centrone F, Chironna M. Anti-MDA5\u2009+\u2009dermatomyositis following SARS-CoV-2 infections: a systematic review. Front Immunol. 2025;16:1565803.","journal-title":"Front Immunol"},{"key":"4272_CR21","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/biomedicines12122800","volume":"12","author":"L Garc\u00eda-Bravo","year":"2024","unstructured":"Garc\u00eda-Bravo L, Prada A, Guti\u00e9rrez LM, Espinosa RE, Almeida GD, Mart\u00edn MD, et al. Increased risk of myositis-specific and myositis-associated autoantibodies after COVID-19 pandemic and vaccination: a Spanish multicenter collaborative study. Biomedicines. 2024;12:2800.","journal-title":"Biomedicines"},{"key":"4272_CR22","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00296-022-05149-6","volume":"42","author":"D Gonzalez","year":"2022","unstructured":"Gonzalez D, Gupta L, Murthy V, Gonzalez EB, Williamson KA, Makol A, et al. Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review. Rheumatol Int. 2022;42:1629\u201341.","journal-title":"Rheumatol Int"},{"key":"4272_CR23","doi-asserted-by":"publisher","first-page":"102898","DOI":"10.1016\/j.jaut.2022.102898","volume":"132","author":"Y Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez Y, Rojas M, Beltr\u00e1n S, Polo F, Camacho-Dom\u00ednguez L, Morales SD, et al. Autoimmune and autoinflammatory conditions after COVID-19 vaccination: new case reports and updated literature review. J Autoimmun. 2022;132:102898.","journal-title":"J Autoimmun"},{"key":"4272_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol. 2020;72:488\u201398.","journal-title":"Arthritis Rheumatol"},{"key":"4272_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/IDR.S392585","volume":"16","author":"M Lao","year":"2023","unstructured":"Lao M, Ouyang H, Li N, Li H, Dai P, Zhan Z, et al. Clinical characteristics and associated factors for infection and in-hospital mortality in inpatients with polymyositis\/dermatomyositis in China: a retrospective study. Infect Drug Resist. 2023;16:289\u201399.","journal-title":"Infect Drug Resist"},{"key":"4272_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.46497\/ArchRheumatol.2022.8719","volume":"37","author":"M Kwon","year":"2021","unstructured":"Kwon M. Spontaneous pneumomediastinum and cutaneous ulcers complicated in a patient with dermatomyositis and interstitial lung disease. Arch Rheumatol. 2021;37:136\u20138.","journal-title":"Arch Rheumatol"},{"key":"4272_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-025-03347-x","volume":"26","author":"J Jin","year":"2025","unstructured":"Jin J, Xu W, Wang H, Wang X, Fu Q, Wu W, et al. Spontaneous pneumomediastinum and\/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system. Respir Res. 2025;26:81.","journal-title":"Respir Res"},{"key":"4272_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.31138\/mjr.060124.pim","volume":"35","author":"R Subramanian","year":"2024","unstructured":"Subramanian R, Prasad R, Mahabaleshwar M, Siddiqui A, Ekbote D, Dhakad U. Pneumomediastinum in MDA5\u2009+\u2009dermatomyositis: a case series. Mediterr J Rheumatol. 2024;35:660\u20137.","journal-title":"Mediterr J Rheumatol"},{"key":"4272_CR29","doi-asserted-by":"publisher","first-page":"e33679","DOI":"10.1016\/j.heliyon.2024.e33679","volume":"10","author":"A Tekin","year":"2024","unstructured":"Tekin A, Devarajan A, Sakata KK, Qamar S, Sharma M, Valencia Morales DJ, et al. Pneumomediastinum and pneumothorax in coronavirus disease-2019: description of a case series and a matched cohort study. Heliyon. 2024;10:e33679.","journal-title":"Heliyon"},{"key":"4272_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4269\/ajtmh.20-0680","volume":"103","author":"A Alhakeem","year":"2020","unstructured":"Alhakeem A, Khan MM, Soub HA, Yousaf Z. Case report: COVID-19-associated bilateral spontaneous pneumothorax\u2014a literature review. Am J Trop Med Hyg. 2020;103:1162\u20135.","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04272-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04272-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04272-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:21:22Z","timestamp":1779240082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04272-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04272-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable due to a case report not including personally identifiable information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the patient passed away during the clinical course, written informed consent was obtained from the patient\u2019s son (next of kin) for the publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}